Alexander Brising
Net worth: 626 290 $ as of 31/05/2026
Net worth: 626 290 $ as of 31/05/2026
Alexander Brising is currently Director-Association of Generic Pharmaceutical at Sweden AB Benning and Baabs AB. Formerly, Mr. Brising was Director-Commercial at EQL Pharma AB from 2016 to 2025 and Head-Sweden at Sandoz A. Mr. Brising completed an MBA at Handelshögskolan i Göteborg.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EQL PHARMA AB 0.79% | 12/09/2025 | 233,644 ( 0.79% ) | 626 290 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Sweden AB Benning | Corporate Officer/Principal | - |
Baabs AB | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| EQL PHARMA AB | Corporate Officer/Principal | 31/12/2025 |
Sandoz A/S
Sandoz A/S Drugstore ChainsRetail Trade Engages in wholesales of pharmaceutical goods | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Sandoz A/S
Sandoz A/S Drugstore ChainsRetail Trade Engages in wholesales of pharmaceutical goods | Retail Trade |
Sweden AB Benning | |
Baabs AB |
Select your edition
All financial news and data tailored to specific country editions